Derechos | Equipo Nizkor
Russian single-component Sputnik Light vaccine authorized in Iran — RDIF
Russian single-component Sputnik Light vaccine has been approved in Iran, the Russian Direct Investment Fund (RDIF) announced on Wednesday.
"RDIF today announced the Russian single-component Sputnik Light vaccine against coronavirus has been approved by the Ministry of Health of the Islamic Republic of Iran," the fund said in a press release.
Sputnik Light vaccine is the first component of the Sputnik V vaccine. Immunization with Sputnik Light will help to speed up the vaccination of the population and create herd immunity in a shorter time frame. In January 2021, the two-dose Sputnik V vaccine was also approved in Iran, RDIF said.
According to the press release, Sputnik Light is safe and highly effective as demonstrated by real-world vaccination data in a number of countries. In particular, the data from the Ministry of Health of the Buenos Aires province (Argentina) shows 78.6-83.7% efficacy among the elderly. In Paraguay, Sputnik Light is 93.5% effective during the ongoing vaccination campaign according to the country’s Ministry of Health.
[Source: Tass, Moscow, 15Sep21]
|This document has been published on 20Sep21 by the Equipo Nizkor and Derechos Human Rights. In accordance with Title 17 U.S.C. Section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes.|